Qigong and Tai Chi for ME/CFS: A Systematic Review of Randomized Controlled Trials.
Markwart, Michaela, Felsenstein, Donna, Mehta, Darshan H et al. · Global advances in integrative medicine and health · 2024 · DOI
Quick Summary
This review looked at studies testing whether Qigong (a gentle Chinese exercise practice) might help people with ME/CFS. Researchers found 5 good-quality studies with a total of 481 people. The results suggest Qigong may help reduce symptom severity and improve both physical and emotional well-being, though more research is needed to be sure. Currently, there are no similar high-quality studies on Tai Chi for ME/CFS.
Why It Matters
ME/CFS lacks effective pharmacological treatments, making non-pharmacological, patient-centered approaches important to explore. This review synthesizes emerging evidence on Qigong as a potentially accessible, low-risk complementary practice that may help patients manage symptoms and improve quality of life. The findings highlight both promise and significant research gaps that future trials must address to establish clinical utility.
Observed Findings
Five Qigong RCTs were identified (N=481 total) spanning 2012-2023, with no high-quality Tai Chi randomized controlled trials found.
Qigong sessions typically lasted 1-2 hours, occurred 5-12 weeks, with a median of 12 and mode of 10-12 sessions.
All Qigong interventions were delivered in group settings and incorporated home practice requirements or recommendations.
Patient-reported outcomes suggested diffuse benefits across physical and emotional health outcomes in ME/CFS populations.
No Tai Chi trials utilized a randomized control design.
Inferred Conclusions
Qigong represents an emerging and relatively understudied but promising mind-body intervention for ME/CFS symptom management.
Future research must implement standardized ME/CFS eligibility criteria and outcome measures to enable meta-analysis and robust efficacy determination.
Integrating Qigong with other empirically supported mind-body and psychological practices may optimize treatment effects and should be explored in future trial designs.
What is the optimal frequency, duration, and structure of Qigong interventions for ME/CFS, and do individual patient characteristics predict better response?
What This Study Does Not Prove
This review does not prove Qigong is an effective treatment for ME/CFS; it only summarizes preliminary patient-reported benefits from a small number of studies. The heterogeneity in interventions, outcome measures, and study quality means definitive efficacy cannot be concluded. Long-term effects and mechanisms of benefit remain unknown, and the absence of Tai Chi RCTs means no conclusions can be drawn about that intervention.
Do Qigong benefits persist after intervention completion, and what mechanisms (physiological, psychological, or behavioral) underlie any observed improvements?
Why have Tai Chi trials not been conducted with randomized control designs, and does Tai Chi show promise in observational or non-randomized studies?
How should Qigong be integrated with other empirically supported treatments, and does combined therapy yield synergistic benefits compared to single interventions?